The Cooper Companies

global medical device company

COO NYSE ISIN US2166484020 SEC CIK 711404 LEI QJKMVPIGLH7530PCUE20
Follow The Cooper Companies Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.1B +0.6% vs same quarter last year
Net income $432.8M +340.3% vs same quarter last year
EPS, diluted $2.24 +357.1% vs same quarter last year
Operating cash flow $341.7M +30.7% vs same quarter last year
Revenue by quarter
$1B
$964.7M
$1B
$1.1B
$1.1B
$1B
$1.1B
$1.1B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
$0$2B$4B$6BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$4.1B$374.9M
FY24$3.9B$392.3M
FY23$3.6B$294.2M
FY22$3.3B$385.8M
FY21$2.9B$2.9B
FY20$2.4B$238.4M
FY19$2.7B$466.7M
FY18$2.5B$139.9M
FY17$2.1B$372.9M
FY16$2B$273.9M
FY15$1.8B$203.5M
FY14$1.7B$269.9M
FY13$1.6B$296.2M
FY12$1.4B$248.3M
FY11$1.3B$175.4M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%50%100%150%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2565.5%16.7%9.2%
FY2466.6%18.1%10.1%
FY2365.6%14.8%8.2%
FY2264.7%15.3%11.7%
FY2166.9%17.3%100.8%
FY2063.1%12.8%9.8%
FY1966.2%20.6%17.6%
FY1864.4%15.9%5.5%
FY1763.9%20.1%17.4%
FY1659.6%16.5%13.9%
FY1559.6%13.2%11.3%
FY1463.5%17.8%15.7%
FY1364.7%19.3%18.7%
FY1263.9%19.6%17.2%
FY1160.5%17.1%13.2%
Free cash flowOperating cash flow minus capital expenditure
$0$200M$400M$600MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$433.7M
FY24$288.1M
FY23$215M
FY22$450.4M
FY21$524.2M
FY20$176.2M
FY19$421.1M
FY18$475.3M
FY17$466.4M
FY16$357M
FY15$147.9M
FY14$216.8M
FY13$237.8M
FY12$215.3M
FY11$232.6M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$100M$200M$300MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$0$290.1M
FY24$0$0
FY23$3M$0
FY22$3M$78.5M
FY21$3M$24.8M
FY20$3M$47.8M
FY19$3M$156.1M
FY18$2.9M$0
FY17$2.9M$55M
FY16$2.9M$0
FY15$2.9M$67.3M
FY14$2.9M$75.8M
FY13$2.9M$167.3M
FY12$2.9M$71.2M
FY11$2.8M$0
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • The Cooper Companies
  • Healthcare median
−100%−50%0%50%100%150%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearThe Cooper CompaniesHealthcare median
FY259.2%−30.6%
FY2410.1%−47%
FY238.2%−58%
FY2211.7%−80.4%
FY21100.8%−71.9%
FY209.8%−62.2%
FY1917.6%−46.3%
FY185.5%−49.6%
FY1717.4%−45.9%
FY1613.9%−36%
FY1511.3%−38.4%
FY1415.7%−35.5%
FY1318.7%−37.1%
FY1217.2%−29.1%
FY1113.2%−27.9%